Statin use and non-melanoma skin cancer risk: a meta-analysis of randomized controlled trials and observational studies.

about

Statin use and non-melanoma skin cancer risk: a meta-analysis of randomized controlled trials and observational studies.

Item

http://www.wikidata.org/entity/Q47106546

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Statin use and non-melanoma sk ...... als and observational studies.

@en

Statin use and non-melanoma sk ...... als and observational studies.

@nl

type

Item

label

Statin use and non-melanoma sk ...... als and observational studies.

@en

Statin use and non-melanoma sk ...... als and observational studies.

@nl

prefLabel

Statin use and non-melanoma sk ...... als and observational studies.

@en

Statin use and non-melanoma sk ...... als and observational studies.

@nl

P1476

Statin use and non-melanoma sk ...... als and observational studies.

@en

P2093

Andrew Marley

http://www.w3.org/2001/XMLSchema#string

Huilin Tang

http://www.w3.org/2001/XMLSchema#string

Jean Y Tang

http://www.w3.org/2001/XMLSchema#string

Jiali Han

http://www.w3.org/2001/XMLSchema#string

Keming Yang

http://www.w3.org/2001/XMLSchema#string

Yiqing Song

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]

A systematic review of worldwide incidence of nonmelanoma skin cancer

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Statin use and breast cancer survival and risk: a systematic review and meta-analysis

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Immune phenotype predicts risk for posttransplantation squamous cell carcinoma.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Non-melanoma skin cancer.

Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis.

P304

75411-75417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20034

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29088876

http://www.w3.org/2001/XMLSchema#string

P921

Non-melanoma Skin Cancer

P932

5650431

http://www.w3.org/2001/XMLSchema#string